SERPINI2
Basic information
Region (hg38): 3:167441914-167478972
Previous symbols: [ "PI14" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SERPINI2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in SERPINI2
This is a list of pathogenic ClinVar variants found in the SERPINI2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-167449318-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
3-167449387-T-A | not specified | Uncertain significance (Jan 03, 2024) | ||
3-167465213-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
3-167465230-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
3-167465270-C-T | not specified | Uncertain significance (Oct 24, 2023) | ||
3-167465344-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
3-167465481-T-A | not specified | Uncertain significance (Jan 10, 2022) | ||
3-167465497-G-T | not specified | Uncertain significance (Sep 16, 2021) | ||
3-167465592-C-G | not specified | Uncertain significance (Aug 12, 2022) | ||
3-167465653-A-T | not specified | Uncertain significance (May 31, 2022) | ||
3-167467094-C-A | not specified | Uncertain significance (Jan 23, 2024) | ||
3-167467232-G-T | not specified | Uncertain significance (Jun 29, 2022) | ||
3-167467247-T-C | not specified | Uncertain significance (May 02, 2024) | ||
3-167467279-T-C | not specified | Uncertain significance (May 28, 2024) | ||
3-167471596-G-C | not specified | Uncertain significance (Mar 16, 2022) | ||
3-167471632-T-C | not specified | Uncertain significance (Jun 07, 2024) | ||
3-167471666-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
3-167471669-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
3-167471713-T-A | not specified | Uncertain significance (May 09, 2022) | ||
3-167471771-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
3-167478907-T-A | not specified | Uncertain significance (Mar 02, 2023) | ||
3-167478956-C-G | not specified | Uncertain significance (Mar 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SERPINI2 | protein_coding | protein_coding | ENST00000476257 | 8 | 37216 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.95e-15 | 0.00852 | 125560 | 0 | 175 | 125735 | 0.000696 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.453 | 177 | 195 | 0.909 | 0.00000860 | 2667 |
Missense in Polyphen | 57 | 69.732 | 0.81742 | 1000 | ||
Synonymous | 1.22 | 54 | 66.6 | 0.810 | 0.00000318 | 720 |
Loss of Function | -0.267 | 21 | 19.7 | 1.06 | 8.32e-7 | 259 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000345 | 0.000331 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.00164 | 0.00163 |
Finnish | 0.00255 | 0.00254 |
European (Non-Finnish) | 0.000613 | 0.000607 |
Middle Eastern | 0.00164 | 0.00163 |
South Asian | 0.000233 | 0.000229 |
Other | 0.000819 | 0.000815 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.431
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.27
Haploinsufficiency Scores
- pHI
- 0.0740
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.414
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.578
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Serpini2
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; immune system phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Gene ontology
- Biological process
- negative regulation of endopeptidase activity
- Cellular component
- extracellular space;extracellular exosome
- Molecular function
- serine-type endopeptidase inhibitor activity;protein binding